Radioiodine Labeling Reagents and Methods for New Chemical Entities and Biomolecules
Cancer Biotherapy and Radiopharmaceuticals · 01.04.2022 · 37 (3) · 173-185
DOI: 10.1089/cbr.2021.0233 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Biotherapy and Radiopharmaceuticals, erschienen am 01.04.2022. Verfasst von Krishan Kumar. Beteiligte Einrichtung: Laboratory for Translational Research in Imaging Pharmaceuticals, The Wright Center of Innovation in Biomedical Imaging, Department of Radiology, The…. Hauptthemen laut MEDLINE: Iodine Radioisotopes, Radiopharmaceuticals. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 95 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory for Translational Research in Imaging Pharmaceuticals, The Wright Center of Innovation in Biomedical Imaging, Department of Radiology, The Ohio State University, Columbus, Ohio, USA.
ORCID-Profile: Krishan Kumar
Zitieren
APA
Kumar, K. (2022). Radioiodine Labeling Reagents and Methods for New Chemical Entities and Biomolecules. Cancer Biotherapy and Radiopharmaceuticals, 37(3), 173-185. https://doi.org/10.1089/cbr.2021.0233
Vancouver
Kumar K. Radioiodine Labeling Reagents and Methods for New Chemical Entities and Biomolecules. Cancer Biotherapy and Radiopharmaceuticals. 2022;37(3):173-185. doi:10.1089/cbr.2021.0233
BibTeX
@article{Kumar2022,
author = {Kumar, Krishan},
title = {Radioiodine Labeling Reagents and Methods for New Chemical Entities and Biomolecules},
journal = {Cancer Biotherapy and Radiopharmaceuticals},
year = {2022},
volume = {37},
number = {3},
pages = {173--185},
doi = {10.1089/cbr.2021.0233}
}
EUVIMED